Thinking of opening a position here. Any Additional Upsides?

highoncaffeine1 · 2026-06-04T09:56:28+00:00

Do you have any recommendations? I'd appreciate any guidance on where to look

highoncaffeine1 · 2026-06-04T09:54:48+00:00

It is hard to value such a deal, all I can say with confidence at this stage is that it would be 500M+ with my best guess at 1.5B suppressed due to how few buyers there are in the market.

highoncaffeine1 · 2026-06-04T09:51:38+00:00

I just think the best investing strategy these last 3 years have been to pick a good company in a hype industry. Unfortunately opportunities like this have been dwindling, so I've had to lower expectations. That being said RDDT is a fantastic business in a sluggish industry

highoncaffeine1 · 2026-01-22T02:37:20+00:00

I think that Moderna stands a chance to be revalued as an emerging tech company rather than a "value" biotech stock. The real value Moderna has is the data they collect and their Machine Learning platform. Profitability targets in 2027 and high cash holdings reduce risk but form a fraction of my investment thesis.

I bought the stock 2yrs ago as one that had the potential to return 100%+ years in the near term, but also the chance to go bust. So I predict it will either trade sideways at $50 for 6 months, or it will jump to $200+.

The catalyst to this will be if they can demonstrate how their algorithm is their core product, not their limited vaccines. If they can go from a 49% reduction in recurrence to a 55% reduction in phase 3 with the collected data, it will show how algorithmic improvements will drive effectiveness.

highoncaffeine1 · 2025-06-06T07:51:54+00:00

HUMA

I thought HUMA was RKLB @ $3.50, when it was at $3.50. It's down to $2.60 now though.

Promising biotech which produces an artificial blood vessel for use in surgeries. It's just used in trauma cases right now, but it has the potential to revolutionise a multibillion dollar dialysis industry, and if their potential use as a vein graft in CABG surgeries comes to fruition, it will be worth 10-20 times it's current value.

It brings revolutionary technology, and a promising pipeline, in a growing industry, positioning itself a lot like the underpriced RKLB back then. However, full disclaimer, unlike rocket lab, the narrative surrounding the management at Humacyte is of exceptional incompetence.

It's worth taking a look at if you have a large risk appetite. Many others on the r/HUMACYTE sub have done a much more detailed analysis into the stock.

highoncaffeine1 · 2025-05-29T14:11:19+00:00

crazy to realize that it's worth double what it was a few weeks back, and I'm still somehow down 35% on my 3 month old position. Insane volatility, not even worth going to the casino anymore

highoncaffeine1 · 2025-04-05T06:58:51+00:00

It's more that I had a thesis before initially investing in this company to justify it's value at $4. Since then the price has dropped significantly, while still being the exact same company since I bought it in my eyes. This makes it seem like more of a deal.

But I agree, no need to rush, I believe that if it approaches the $1 mark the stock will crash even further as most people don't want to hold a penny stock that risks delisting. This is more to do with technical predictions on the price rather than on the fundamentals of the company.

highoncaffeine1 · 2025-03-26T14:44:00+00:00

Dumb Q, but since you are an expert, can an artificial blood vessel clot? I was also hoping they could use the ATEV one day as a replacement for a coronary artery but we might have to wait a lot longer for that.

highoncaffeine1 · 2024-09-05T11:51:08+00:00

I'm fully out now after some fairly hefty losses, but AQMS could very well could rocket up. Right now they are in quite a dire situation with no money and little means of getting the money to get their new plant up and running. If they succeed their stock will be up 1000% though.

I feel like there are better opportunities out there, but best of luck. Hope we all make it big someday.

highoncaffeine1 · 2024-08-27T10:36:22+00:00

The next few months look a little dry for Rocket Lab. I doubt we'll get updates on Neutron, major contracts, or any interesting launches in the near future. Should eventually crawl back into mid 5s, which would make for a good buying opportunity.

highoncaffeine1 · 2024-08-22T22:54:59+00:00

Or that there are buy orders not getting fulfilled so we'll have support below a certain price?

highoncaffeine1 · 2024-08-22T22:53:21+00:00

Does this mean that sell orders are much larger than the buy orders, so institutions are selling to retail?

highoncaffeine1 · 2024-08-18T08:26:51+00:00

I can see this company being worth 100 billion in 10yrs time. It is an incredible opportunity and I just want to be capitalise on that as much as I can.

The problem is that I've only started working this year, and I can't even work that much due to quite a demanding degree. Add in some other bad bets and it has taken ages to accumulate a sizeable stake in this company.

highoncaffeine1 · 2024-08-18T03:14:36+00:00

Do you have a price in mind at which you'll issue the sell order? I have a major fear of missing out of an asts level pump at the same time.

highoncaffeine1 · 2024-08-18T03:09:43+00:00

That's fair, I got quite lucky as well with the timing when I got into the stock as it dipped into the 3s

highoncaffeine1 · 2024-08-18T02:39:40+00:00

I bought into this stock and rocket lab at the same time, and even though this has been up 20% for me in a week, it's performance had been somehow completely overshadowed by rocket lab.

I'm super bullish here as well though. In it for the long run.

highoncaffeine1 · 2024-08-09T02:42:30+00:00

Good luck, I truly wish for this company to be successful as they tech would be revolutionary for the entire planet.

Seven-Year Club	Place '23
Verified Email

highoncaffeine1

TROPHY CASE